2026 7th Character ICD-10-CM Codes - Page 80

The 2026 7th Character ICD-10-CM Codes list includes 51,485 codes requiring a seventh character to indicate the type of encounter: initial, subsequent, or sequela. These codes are essential for injuries, poisonings, fractures, and other external cause conditions. Using the correct 7th character ensures claims reflect the patient’s treatment stage, supports accurate reimbursement, and prevents errors or denials. Coders must confirm that documentation supports the encounter type assigned.

  • T46.0X1A - Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter Billable

  • T46.0X1D - Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter Billable

  • T46.0X1S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela Billable

  • T46.0X2A - Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter Billable

  • T46.0X2D - Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter Billable

  • T46.0X2S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela Billable

  • T46.0X3A - Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter Billable

  • T46.0X3D - Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter Billable

  • T46.0X3S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela Billable

  • T46.0X4A - Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter Billable

  • T46.0X4D - Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter Billable

  • T46.0X4S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela Billable

  • T46.0X5A - Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter Billable

  • T46.0X5D - Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter Billable

  • T46.0X5S - Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela Billable

  • T46.0X6A - Underdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter Billable

  • T46.0X6D - Underdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter Billable

  • T46.0X6S - Underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela Billable

  • T46.1X1A - Poisoning by calcium-channel blockers, accidental (unintentional), initial encounter Billable

  • T46.1X1D - Poisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter Billable

  • T46.1X1S - Poisoning by calcium-channel blockers, accidental (unintentional), sequela Billable

  • T46.1X2A - Poisoning by calcium-channel blockers, intentional self-harm, initial encounter Billable

  • T46.1X2D - Poisoning by calcium-channel blockers, intentional self-harm, subsequent encounter Billable

  • T46.1X2S - Poisoning by calcium-channel blockers, intentional self-harm, sequela Billable

  • T46.1X3A - Poisoning by calcium-channel blockers, assault, initial encounter Billable

  • T46.1X3D - Poisoning by calcium-channel blockers, assault, subsequent encounter Billable

  • T46.1X3S - Poisoning by calcium-channel blockers, assault, sequela Billable

  • T46.1X4A - Poisoning by calcium-channel blockers, undetermined, initial encounter Billable

  • T46.1X4D - Poisoning by calcium-channel blockers, undetermined, subsequent encounter Billable

  • T46.1X4S - Poisoning by calcium-channel blockers, undetermined, sequela Billable

  • T46.1X5A - Adverse effect of calcium-channel blockers, initial encounter Billable

  • T46.1X5D - Adverse effect of calcium-channel blockers, subsequent encounter Billable

  • T46.1X5S - Adverse effect of calcium-channel blockers, sequela Billable

  • T46.1X6A - Underdosing of calcium-channel blockers, initial encounter Billable

  • T46.1X6D - Underdosing of calcium-channel blockers, subsequent encounter Billable

  • T46.1X6S - Underdosing of calcium-channel blockers, sequela Billable

  • T46.2X1A - Poisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter Billable

  • T46.2X1D - Poisoning by other antidysrhythmic drugs, accidental (unintentional), subsequent encounter Billable

  • T46.2X1S - Poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela Billable

  • T46.2X2A - Poisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter Billable

  • T46.2X2D - Poisoning by other antidysrhythmic drugs, intentional self-harm, subsequent encounter Billable

  • T46.2X2S - Poisoning by other antidysrhythmic drugs, intentional self-harm, sequela Billable

  • T46.2X3A - Poisoning by other antidysrhythmic drugs, assault, initial encounter Billable

  • T46.2X3D - Poisoning by other antidysrhythmic drugs, assault, subsequent encounter Billable

  • T46.2X3S - Poisoning by other antidysrhythmic drugs, assault, sequela Billable

  • T46.2X4A - Poisoning by other antidysrhythmic drugs, undetermined, initial encounter Billable

  • T46.2X4D - Poisoning by other antidysrhythmic drugs, undetermined, subsequent encounter Billable

  • T46.2X4S - Poisoning by other antidysrhythmic drugs, undetermined, sequela Billable

  • T46.2X5A - Adverse effect of other antidysrhythmic drugs, initial encounter Billable

  • T46.2X5D - Adverse effect of other antidysrhythmic drugs, subsequent encounter Billable

  • T46.2X5S - Adverse effect of other antidysrhythmic drugs, sequela Billable

  • T46.2X6A - Underdosing of other antidysrhythmic drugs, initial encounter Billable

  • T46.2X6D - Underdosing of other antidysrhythmic drugs, subsequent encounter Billable

  • T46.2X6S - Underdosing of other antidysrhythmic drugs, sequela Billable

  • T46.3X1A - Poisoning by coronary vasodilators, accidental (unintentional), initial encounter Billable

  • T46.3X1D - Poisoning by coronary vasodilators, accidental (unintentional), subsequent encounter Billable

  • T46.3X1S - Poisoning by coronary vasodilators, accidental (unintentional), sequela Billable

  • T46.3X2A - Poisoning by coronary vasodilators, intentional self-harm, initial encounter Billable

  • T46.3X2D - Poisoning by coronary vasodilators, intentional self-harm, subsequent encounter Billable

  • T46.3X2S - Poisoning by coronary vasodilators, intentional self-harm, sequela Billable

  • T46.3X3A - Poisoning by coronary vasodilators, assault, initial encounter Billable

  • T46.3X3D - Poisoning by coronary vasodilators, assault, subsequent encounter Billable

  • T46.3X3S - Poisoning by coronary vasodilators, assault, sequela Billable

  • T46.3X4A - Poisoning by coronary vasodilators, undetermined, initial encounter Billable

  • T46.3X4D - Poisoning by coronary vasodilators, undetermined, subsequent encounter Billable

  • T46.3X4S - Poisoning by coronary vasodilators, undetermined, sequela Billable

  • T46.3X5A - Adverse effect of coronary vasodilators, initial encounter Billable

  • T46.3X5D - Adverse effect of coronary vasodilators, subsequent encounter Billable

  • T46.3X5S - Adverse effect of coronary vasodilators, sequela Billable

  • T46.3X6A - Underdosing of coronary vasodilators, initial encounter Billable

  • T46.3X6D - Underdosing of coronary vasodilators, subsequent encounter Billable

  • T46.3X6S - Underdosing of coronary vasodilators, sequela Billable

  • T46.4X1A - Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter Billable

  • T46.4X1D - Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), subsequent encounter Billable

  • T46.4X1S - Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequela Billable

  • T46.4X2A - Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter Billable

  • T46.4X2D - Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounter Billable

  • T46.4X2S - Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela Billable

  • T46.4X3A - Poisoning by angiotensin-converting-enzyme inhibitors, assault, initial encounter Billable

  • T46.4X3D - Poisoning by angiotensin-converting-enzyme inhibitors, assault, subsequent encounter Billable

  • T46.4X3S - Poisoning by angiotensin-converting-enzyme inhibitors, assault, sequela Billable

  • T46.4X4A - Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, initial encounter Billable

  • T46.4X4D - Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, subsequent encounter Billable

  • T46.4X4S - Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, sequela Billable

  • T46.4X5A - Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter Billable

  • T46.4X5D - Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter Billable

  • T46.4X5S - Adverse effect of angiotensin-converting-enzyme inhibitors, sequela Billable

  • T46.4X6A - Underdosing of angiotensin-converting-enzyme inhibitors, initial encounter Billable

  • T46.4X6D - Underdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter Billable

  • T46.4X6S - Underdosing of angiotensin-converting-enzyme inhibitors, sequela Billable

  • T46.5X1A - Poisoning by other antihypertensive drugs, accidental (unintentional), initial encounter Billable

  • T46.5X1D - Poisoning by other antihypertensive drugs, accidental (unintentional), subsequent encounter Billable

  • T46.5X1S - Poisoning by other antihypertensive drugs, accidental (unintentional), sequela Billable

  • T46.5X2A - Poisoning by other antihypertensive drugs, intentional self-harm, initial encounter Billable

  • T46.5X2D - Poisoning by other antihypertensive drugs, intentional self-harm, subsequent encounter Billable

  • T46.5X2S - Poisoning by other antihypertensive drugs, intentional self-harm, sequela Billable

  • T46.5X3A - Poisoning by other antihypertensive drugs, assault, initial encounter Billable

  • T46.5X3D - Poisoning by other antihypertensive drugs, assault, subsequent encounter Billable

  • T46.5X3S - Poisoning by other antihypertensive drugs, assault, sequela Billable

  • T46.5X4A - Poisoning by other antihypertensive drugs, undetermined, initial encounter Billable

  • T46.5X4D - Poisoning by other antihypertensive drugs, undetermined, subsequent encounter Billable

  • T46.5X4S - Poisoning by other antihypertensive drugs, undetermined, sequela Billable

  • T46.5X5A - Adverse effect of other antihypertensive drugs, initial encounter Billable

  • T46.5X5D - Adverse effect of other antihypertensive drugs, subsequent encounter Billable

  • T46.5X5S - Adverse effect of other antihypertensive drugs, sequela Billable

  • T46.5X6A - Underdosing of other antihypertensive drugs, initial encounter Billable

  • T46.5X6D - Underdosing of other antihypertensive drugs, subsequent encounter Billable

  • T46.5X6S - Underdosing of other antihypertensive drugs, sequela Billable

  • T46.6X1A - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial encounter Billable

  • T46.6X1D - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), subsequent encounter Billable

  • T46.6X1S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela Billable

  • T46.6X2A - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, initial encounter Billable

  • T46.6X2D - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, subsequent encounter Billable

  • T46.6X2S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, sequela Billable

  • T46.6X3A - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, initial encounter Billable

  • T46.6X3D - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, subsequent encounter Billable

  • T46.6X3S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, sequela Billable

  • T46.6X4A - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, initial encounter Billable

  • T46.6X4D - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, subsequent encounter Billable

  • T46.6X4S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, sequela Billable

  • T46.6X5A - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter Billable

  • T46.6X5D - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter Billable

  • T46.6X5S - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela Billable

  • T46.6X6A - Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter Billable

  • T46.6X6D - Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter Billable

  • T46.6X6S - Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela Billable

  • T46.7X1A - Poisoning by peripheral vasodilators, accidental (unintentional), initial encounter Billable

  • T46.7X1D - Poisoning by peripheral vasodilators, accidental (unintentional), subsequent encounter Billable

  • T46.7X1S - Poisoning by peripheral vasodilators, accidental (unintentional), sequela Billable

  • T46.7X2A - Poisoning by peripheral vasodilators, intentional self-harm, initial encounter Billable

  • T46.7X2D - Poisoning by peripheral vasodilators, intentional self-harm, subsequent encounter Billable

  • T46.7X2S - Poisoning by peripheral vasodilators, intentional self-harm, sequela Billable

  • T46.7X3A - Poisoning by peripheral vasodilators, assault, initial encounter Billable

  • T46.7X3D - Poisoning by peripheral vasodilators, assault, subsequent encounter Billable

  • T46.7X3S - Poisoning by peripheral vasodilators, assault, sequela Billable

  • T46.7X4A - Poisoning by peripheral vasodilators, undetermined, initial encounter Billable

  • T46.7X4D - Poisoning by peripheral vasodilators, undetermined, subsequent encounter Billable

  • T46.7X4S - Poisoning by peripheral vasodilators, undetermined, sequela Billable

  • T46.7X5A - Adverse effect of peripheral vasodilators, initial encounter Billable

  • T46.7X5D - Adverse effect of peripheral vasodilators, subsequent encounter Billable

  • T46.7X5S - Adverse effect of peripheral vasodilators, sequela Billable

  • T46.7X6A - Underdosing of peripheral vasodilators, initial encounter Billable

  • T46.7X6D - Underdosing of peripheral vasodilators, subsequent encounter Billable

  • T46.7X6S - Underdosing of peripheral vasodilators, sequela Billable

  • T46.8X1A - Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter Billable

  • T46.8X1D - Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter Billable

  • T46.8X1S - Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela Billable

  • T46.8X2A - Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter Billable

  • T46.8X2D - Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter Billable

  • T46.8X2S - Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela Billable

  • T46.8X3A - Poisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter Billable

  • T46.8X3D - Poisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounter Billable

  • T46.8X3S - Poisoning by antivaricose drugs, including sclerosing agents, assault, sequela Billable

  • T46.8X4A - Poisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter Billable

  • T46.8X4D - Poisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter Billable

  • T46.8X4S - Poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela Billable

  • T46.8X5A - Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter Billable

  • T46.8X5D - Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter Billable

  • T46.8X5S - Adverse effect of antivaricose drugs, including sclerosing agents, sequela Billable

  • T46.8X6A - Underdosing of antivaricose drugs, including sclerosing agents, initial encounter Billable

  • T46.8X6D - Underdosing of antivaricose drugs, including sclerosing agents, subsequent encounter Billable

  • T46.8X6S - Underdosing of antivaricose drugs, including sclerosing agents, sequela Billable

  • T46.901A - Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter Billable

  • T46.901D - Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter Billable

  • T46.901S - Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela Billable

  • T46.902A - Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter Billable

  • T46.902D - Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter Billable

  • T46.902S - Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela Billable

  • T46.903A - Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter Billable

  • T46.903D - Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounter Billable

  • T46.903S - Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela Billable

  • T46.904A - Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, initial encounter Billable

  • T46.904D - Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, subsequent encounter Billable

  • T46.904S - Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequela Billable

  • T46.905A - Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter Billable

  • T46.905D - Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter Billable

  • T46.905S - Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela Billable

  • T46.906A - Underdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter Billable

  • T46.906D - Underdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter Billable

  • T46.906S - Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela Billable

  • T46.991A - Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter Billable

  • T46.991D - Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter Billable

  • T46.991S - Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), sequela Billable

  • T46.992A - Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter Billable

  • T46.992D - Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter Billable

  • T46.992S - Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, sequela Billable

  • T46.993A - Poisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter Billable

  • T46.993D - Poisoning by other agents primarily affecting the cardiovascular system, assault, subsequent encounter Billable

  • T46.993S - Poisoning by other agents primarily affecting the cardiovascular system, assault, sequela Billable

  • T46.994A - Poisoning by other agents primarily affecting the cardiovascular system, undetermined, initial encounter Billable

  • T46.994D - Poisoning by other agents primarily affecting the cardiovascular system, undetermined, subsequent encounter Billable

  • T46.994S - Poisoning by other agents primarily affecting the cardiovascular system, undetermined, sequela Billable

  • T46.995A - Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter Billable

  • T46.995D - Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter Billable

  • T46.995S - Adverse effect of other agents primarily affecting the cardiovascular system, sequela Billable

  • T46.996A - Underdosing of other agents primarily affecting the cardiovascular system, initial encounter Billable

  • T46.996D - Underdosing of other agents primarily affecting the cardiovascular system, subsequent encounter Billable

  • T46.996S - Underdosing of other agents primarily affecting the cardiovascular system, sequela Billable

  • T47.0X1A - Poisoning by histamine H2-receptor blockers, accidental (unintentional), initial encounter Billable

  • T47.0X1D - Poisoning by histamine H2-receptor blockers, accidental (unintentional), subsequent encounter Billable

  • T47.0X1S - Poisoning by histamine H2-receptor blockers, accidental (unintentional), sequela Billable

  • T47.0X2A - Poisoning by histamine H2-receptor blockers, intentional self-harm, initial encounter Billable

  • T47.0X2D - Poisoning by histamine H2-receptor blockers, intentional self-harm, subsequent encounter Billable

  • T47.0X2S - Poisoning by histamine H2-receptor blockers, intentional self-harm, sequela Billable

  • T47.0X3A - Poisoning by histamine H2-receptor blockers, assault, initial encounter Billable

  • T47.0X3D - Poisoning by histamine H2-receptor blockers, assault, subsequent encounter Billable

  • T47.0X3S - Poisoning by histamine H2-receptor blockers, assault, sequela Billable

  • T47.0X4A - Poisoning by histamine H2-receptor blockers, undetermined, initial encounter Billable

  • T47.0X4D - Poisoning by histamine H2-receptor blockers, undetermined, subsequent encounter Billable

  • T47.0X4S - Poisoning by histamine H2-receptor blockers, undetermined, sequela Billable

  • T47.0X5A - Adverse effect of histamine H2-receptor blockers, initial encounter Billable

  • T47.0X5D - Adverse effect of histamine H2-receptor blockers, subsequent encounter Billable

  • T47.0X5S - Adverse effect of histamine H2-receptor blockers, sequela Billable

  • T47.0X6A - Underdosing of histamine H2-receptor blockers, initial encounter Billable

  • T47.0X6D - Underdosing of histamine H2-receptor blockers, subsequent encounter Billable

  • T47.0X6S - Underdosing of histamine H2-receptor blockers, sequela Billable

  • T47.1X1A - Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), initial encounter Billable

  • T47.1X1D - Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), subsequent encounter Billable

  • T47.1X1S - Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), sequela Billable

  • T47.1X2A - Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, initial encounter Billable

  • T47.1X2D - Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, subsequent encounter Billable

  • T47.1X2S - Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, sequela Billable

  • T47.1X3A - Poisoning by other antacids and anti-gastric-secretion drugs, assault, initial encounter Billable

  • T47.1X3D - Poisoning by other antacids and anti-gastric-secretion drugs, assault, subsequent encounter Billable

  • T47.1X3S - Poisoning by other antacids and anti-gastric-secretion drugs, assault, sequela Billable

  • T47.1X4A - Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, initial encounter Billable

  • T47.1X4D - Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, subsequent encounter Billable

  • T47.1X4S - Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, sequela Billable

  • T47.1X5A - Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter Billable

  • T47.1X5D - Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter Billable

  • T47.1X5S - Adverse effect of other antacids and anti-gastric-secretion drugs, sequela Billable

  • T47.1X6A - Underdosing of other antacids and anti-gastric-secretion drugs, initial encounter Billable

  • T47.1X6D - Underdosing of other antacids and anti-gastric-secretion drugs, subsequent encounter Billable

  • T47.1X6S - Underdosing of other antacids and anti-gastric-secretion drugs, sequela Billable

  • T47.2X1A - Poisoning by stimulant laxatives, accidental (unintentional), initial encounter Billable

  • T47.2X1D - Poisoning by stimulant laxatives, accidental (unintentional), subsequent encounter Billable

  • T47.2X1S - Poisoning by stimulant laxatives, accidental (unintentional), sequela Billable

  • T47.2X2A - Poisoning by stimulant laxatives, intentional self-harm, initial encounter Billable

  • T47.2X2D - Poisoning by stimulant laxatives, intentional self-harm, subsequent encounter Billable

  • T47.2X2S - Poisoning by stimulant laxatives, intentional self-harm, sequela Billable

  • T47.2X3A - Poisoning by stimulant laxatives, assault, initial encounter Billable

  • T47.2X3D - Poisoning by stimulant laxatives, assault, subsequent encounter Billable

  • T47.2X3S - Poisoning by stimulant laxatives, assault, sequela Billable

  • T47.2X4A - Poisoning by stimulant laxatives, undetermined, initial encounter Billable

  • T47.2X4D - Poisoning by stimulant laxatives, undetermined, subsequent encounter Billable

  • T47.2X4S - Poisoning by stimulant laxatives, undetermined, sequela Billable

  • T47.2X5A - Adverse effect of stimulant laxatives, initial encounter Billable

  • T47.2X5D - Adverse effect of stimulant laxatives, subsequent encounter Billable

  • T47.2X5S - Adverse effect of stimulant laxatives, sequela Billable

  • T47.2X6A - Underdosing of stimulant laxatives, initial encounter Billable

  • T47.2X6D - Underdosing of stimulant laxatives, subsequent encounter Billable

  • T47.2X6S - Underdosing of stimulant laxatives, sequela Billable

  • T47.3X1A - Poisoning by saline and osmotic laxatives, accidental (unintentional), initial encounter Billable

  • T47.3X1D - Poisoning by saline and osmotic laxatives, accidental (unintentional), subsequent encounter Billable

  • T47.3X1S - Poisoning by saline and osmotic laxatives, accidental (unintentional), sequela Billable

  • T47.3X2A - Poisoning by saline and osmotic laxatives, intentional self-harm, initial encounter Billable

  • T47.3X2D - Poisoning by saline and osmotic laxatives, intentional self-harm, subsequent encounter Billable

  • T47.3X2S - Poisoning by saline and osmotic laxatives, intentional self-harm, sequela Billable

  • T47.3X3A - Poisoning by saline and osmotic laxatives, assault, initial encounter Billable

  • T47.3X3D - Poisoning by saline and osmotic laxatives, assault, subsequent encounter Billable

  • T47.3X3S - Poisoning by saline and osmotic laxatives, assault, sequela Billable

  • T47.3X4A - Poisoning by saline and osmotic laxatives, undetermined, initial encounter Billable

  • T47.3X4D - Poisoning by saline and osmotic laxatives, undetermined, subsequent encounter Billable

  • T47.3X4S - Poisoning by saline and osmotic laxatives, undetermined, sequela Billable

  • T47.3X5A - Adverse effect of saline and osmotic laxatives, initial encounter Billable

  • T47.3X5D - Adverse effect of saline and osmotic laxatives, subsequent encounter Billable

  • T47.3X5S - Adverse effect of saline and osmotic laxatives, sequela Billable

  • T47.3X6A - Underdosing of saline and osmotic laxatives, initial encounter Billable

  • T47.3X6D - Underdosing of saline and osmotic laxatives, subsequent encounter Billable

  • T47.3X6S - Underdosing of saline and osmotic laxatives, sequela Billable

  • T47.4X1A - Poisoning by other laxatives, accidental (unintentional), initial encounter Billable

  • T47.4X1D - Poisoning by other laxatives, accidental (unintentional), subsequent encounter Billable

  • T47.4X1S - Poisoning by other laxatives, accidental (unintentional), sequela Billable

  • T47.4X2A - Poisoning by other laxatives, intentional self-harm, initial encounter Billable

  • T47.4X2D - Poisoning by other laxatives, intentional self-harm, subsequent encounter Billable

  • T47.4X2S - Poisoning by other laxatives, intentional self-harm, sequela Billable

  • T47.4X3A - Poisoning by other laxatives, assault, initial encounter Billable

  • T47.4X3D - Poisoning by other laxatives, assault, subsequent encounter Billable

  • T47.4X3S - Poisoning by other laxatives, assault, sequela Billable

  • T47.4X4A - Poisoning by other laxatives, undetermined, initial encounter Billable

  • T47.4X4D - Poisoning by other laxatives, undetermined, subsequent encounter Billable

  • T47.4X4S - Poisoning by other laxatives, undetermined, sequela Billable

  • T47.4X5A - Adverse effect of other laxatives, initial encounter Billable

  • T47.4X5D - Adverse effect of other laxatives, subsequent encounter Billable

  • T47.4X5S - Adverse effect of other laxatives, sequela Billable

  • T47.4X6A - Underdosing of other laxatives, initial encounter Billable

  • T47.4X6D - Underdosing of other laxatives, subsequent encounter Billable

  • T47.4X6S - Underdosing of other laxatives, sequela Billable

  • T47.5X1A - Poisoning by digestants, accidental (unintentional), initial encounter Billable

  • T47.5X1D - Poisoning by digestants, accidental (unintentional), subsequent encounter Billable

  • T47.5X1S - Poisoning by digestants, accidental (unintentional), sequela Billable

  • T47.5X2A - Poisoning by digestants, intentional self-harm, initial encounter Billable

  • T47.5X2D - Poisoning by digestants, intentional self-harm, subsequent encounter Billable

  • T47.5X2S - Poisoning by digestants, intentional self-harm, sequela Billable

  • T47.5X3A - Poisoning by digestants, assault, initial encounter Billable

  • T47.5X3D - Poisoning by digestants, assault, subsequent encounter Billable

  • T47.5X3S - Poisoning by digestants, assault, sequela Billable

  • T47.5X4A - Poisoning by digestants, undetermined, initial encounter Billable

  • T47.5X4D - Poisoning by digestants, undetermined, subsequent encounter Billable

  • T47.5X4S - Poisoning by digestants, undetermined, sequela Billable

  • T47.5X5A - Adverse effect of digestants, initial encounter Billable

  • T47.5X5D - Adverse effect of digestants, subsequent encounter Billable

  • T47.5X5S - Adverse effect of digestants, sequela Billable

  • T47.5X6A - Underdosing of digestants, initial encounter Billable

  • T47.5X6D - Underdosing of digestants, subsequent encounter Billable

  • T47.5X6S - Underdosing of digestants, sequela Billable

  • T47.6X1A - Poisoning by antidiarrheal drugs, accidental (unintentional), initial encounter Billable

  • T47.6X1D - Poisoning by antidiarrheal drugs, accidental (unintentional), subsequent encounter Billable

  • T47.6X1S - Poisoning by antidiarrheal drugs, accidental (unintentional), sequela Billable

  • T47.6X2A - Poisoning by antidiarrheal drugs, intentional self-harm, initial encounter Billable

  • T47.6X2D - Poisoning by antidiarrheal drugs, intentional self-harm, subsequent encounter Billable

  • T47.6X2S - Poisoning by antidiarrheal drugs, intentional self-harm, sequela Billable

  • T47.6X3A - Poisoning by antidiarrheal drugs, assault, initial encounter Billable

  • T47.6X3D - Poisoning by antidiarrheal drugs, assault, subsequent encounter Billable

  • T45.4X5A - Adverse effect of iron and its compounds, initial encounter Billable

  • T45.4X5D - Adverse effect of iron and its compounds, subsequent encounter Billable

  • T45.4X5S - Adverse effect of iron and its compounds, sequela Billable

  • T45.4X6A - Underdosing of iron and its compounds, initial encounter Billable

  • T45.4X6D - Underdosing of iron and its compounds, subsequent encounter Billable

  • T45.4X6S - Underdosing of iron and its compounds, sequela Billable

  • T45.511A - Poisoning by anticoagulants, accidental (unintentional), initial encounter Billable

  • T45.511D - Poisoning by anticoagulants, accidental (unintentional), subsequent encounter Billable

  • T45.511S - Poisoning by anticoagulants, accidental (unintentional), sequela Billable

  • T45.512A - Poisoning by anticoagulants, intentional self-harm, initial encounter Billable

  • T45.512D - Poisoning by anticoagulants, intentional self-harm, subsequent encounter Billable

  • T45.512S - Poisoning by anticoagulants, intentional self-harm, sequela Billable

  • T45.513A - Poisoning by anticoagulants, assault, initial encounter Billable

  • T45.513D - Poisoning by anticoagulants, assault, subsequent encounter Billable

  • T45.513S - Poisoning by anticoagulants, assault, sequela Billable

  • T45.514A - Poisoning by anticoagulants, undetermined, initial encounter Billable

  • T45.514D - Poisoning by anticoagulants, undetermined, subsequent encounter Billable

  • T45.514S - Poisoning by anticoagulants, undetermined, sequela Billable

  • T45.515A - Adverse effect of anticoagulants, initial encounter Billable

  • T45.515D - Adverse effect of anticoagulants, subsequent encounter Billable

  • T45.515S - Adverse effect of anticoagulants, sequela Billable

  • T45.516A - Underdosing of anticoagulants, initial encounter Billable

  • T45.516D - Underdosing of anticoagulants, subsequent encounter Billable

  • T45.516S - Underdosing of anticoagulants, sequela Billable

  • T45.521A - Poisoning by antithrombotic drugs, accidental (unintentional), initial encounter Billable

  • T45.521D - Poisoning by antithrombotic drugs, accidental (unintentional), subsequent encounter Billable

  • T45.521S - Poisoning by antithrombotic drugs, accidental (unintentional), sequela Billable

  • T45.522A - Poisoning by antithrombotic drugs, intentional self-harm, initial encounter Billable

  • T45.522D - Poisoning by antithrombotic drugs, intentional self-harm, subsequent encounter Billable

  • T45.522S - Poisoning by antithrombotic drugs, intentional self-harm, sequela Billable

  • T45.523A - Poisoning by antithrombotic drugs, assault, initial encounter Billable

  • T45.523D - Poisoning by antithrombotic drugs, assault, subsequent encounter Billable

  • T45.523S - Poisoning by antithrombotic drugs, assault, sequela Billable

  • T45.524A - Poisoning by antithrombotic drugs, undetermined, initial encounter Billable

  • T45.524D - Poisoning by antithrombotic drugs, undetermined, subsequent encounter Billable

  • T45.524S - Poisoning by antithrombotic drugs, undetermined, sequela Billable

  • T45.525A - Adverse effect of antithrombotic drugs, initial encounter Billable

  • T45.525D - Adverse effect of antithrombotic drugs, subsequent encounter Billable

  • T45.525S - Adverse effect of antithrombotic drugs, sequela Billable

  • T45.526A - Underdosing of antithrombotic drugs, initial encounter Billable

  • T45.526D - Underdosing of antithrombotic drugs, subsequent encounter Billable

  • T45.526S - Underdosing of antithrombotic drugs, sequela Billable

  • T45.601A - Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), initial encounter Billable

  • T45.601D - Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), subsequent encounter Billable

  • T45.601S - Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), sequela Billable

  • T45.602A - Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, initial encounter Billable

  • T45.602D - Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter Billable

  • T45.602S - Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, sequela Billable

  • T45.603A - Poisoning by unspecified fibrinolysis-affecting drugs, assault, initial encounter Billable

  • T45.603D - Poisoning by unspecified fibrinolysis-affecting drugs, assault, subsequent encounter Billable

  • T45.603S - Poisoning by unspecified fibrinolysis-affecting drugs, assault, sequela Billable

  • T45.604A - Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, initial encounter Billable

  • T45.604D - Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, subsequent encounter Billable

  • T45.604S - Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, sequela Billable

  • T45.605A - Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter Billable

  • T45.605D - Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter Billable

  • T45.605S - Adverse effect of unspecified fibrinolysis-affecting drugs, sequela Billable

  • T45.606A - Underdosing of unspecified fibrinolysis-affecting drugs, initial encounter Billable

  • T45.606D - Underdosing of unspecified fibrinolysis-affecting drugs, subsequent encounter Billable

  • T45.606S - Underdosing of unspecified fibrinolysis-affecting drugs, sequela Billable

  • T45.611A - Poisoning by thrombolytic drug, accidental (unintentional), initial encounter Billable

  • T45.611D - Poisoning by thrombolytic drug, accidental (unintentional), subsequent encounter Billable

  • T45.611S - Poisoning by thrombolytic drug, accidental (unintentional), sequela Billable

  • T45.612A - Poisoning by thrombolytic drug, intentional self-harm, initial encounter Billable

  • T45.612D - Poisoning by thrombolytic drug, intentional self-harm, subsequent encounter Billable

  • T45.612S - Poisoning by thrombolytic drug, intentional self-harm, sequela Billable

  • T45.613A - Poisoning by thrombolytic drug, assault, initial encounter Billable

  • T45.613D - Poisoning by thrombolytic drug, assault, subsequent encounter Billable

  • T45.613S - Poisoning by thrombolytic drug, assault, sequela Billable

  • T45.614A - Poisoning by thrombolytic drug, undetermined, initial encounter Billable

  • T45.614D - Poisoning by thrombolytic drug, undetermined, subsequent encounter Billable

  • T45.614S - Poisoning by thrombolytic drug, undetermined, sequela Billable

  • T45.615A - Adverse effect of thrombolytic drugs, initial encounter Billable

  • T45.615D - Adverse effect of thrombolytic drugs, subsequent encounter Billable

  • T45.615S - Adverse effect of thrombolytic drugs, sequela Billable

  • T45.616A - Underdosing of thrombolytic drugs, initial encounter Billable

  • T45.616D - Underdosing of thrombolytic drugs, subsequent encounter Billable

  • T45.616S - Underdosing of thrombolytic drugs, sequela Billable

  • T45.621A - Poisoning by hemostatic drug, accidental (unintentional), initial encounter Billable

  • T45.621D - Poisoning by hemostatic drug, accidental (unintentional), subsequent encounter Billable

  • T45.621S - Poisoning by hemostatic drug, accidental (unintentional), sequela Billable

  • T45.622A - Poisoning by hemostatic drug, intentional self-harm, initial encounter Billable

  • T45.622D - Poisoning by hemostatic drug, intentional self-harm, subsequent encounter Billable

  • T45.622S - Poisoning by hemostatic drug, intentional self-harm, sequela Billable

  • T45.623A - Poisoning by hemostatic drug, assault, initial encounter Billable

  • T45.623D - Poisoning by hemostatic drug, assault, subsequent encounter Billable

  • T45.623S - Poisoning by hemostatic drug, assault, sequela Billable

  • T45.624A - Poisoning by hemostatic drug, undetermined, initial encounter Billable

  • T45.624D - Poisoning by hemostatic drug, undetermined, subsequent encounter Billable

  • T45.624S - Poisoning by hemostatic drug, undetermined, sequela Billable

  • T45.625A - Adverse effect of hemostatic drug, initial encounter Billable

  • T45.625D - Adverse effect of hemostatic drug, subsequent encounter Billable

  • T45.625S - Adverse effect of hemostatic drug, sequela Billable

  • T45.626A - Underdosing of hemostatic drugs, initial encounter Billable

  • T45.626D - Underdosing of hemostatic drugs, subsequent encounter Billable

  • T45.626S - Underdosing of hemostatic drugs, sequela Billable

  • T45.691A - Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), initial encounter Billable

  • T45.691D - Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), subsequent encounter Billable

  • T45.691S - Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), sequela Billable

  • T45.692A - Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, initial encounter Billable

  • T45.692D - Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter Billable

  • T45.692S - Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, sequela Billable

  • T45.693A - Poisoning by other fibrinolysis-affecting drugs, assault, initial encounter Billable

  • T45.693D - Poisoning by other fibrinolysis-affecting drugs, assault, subsequent encounter Billable

  • T45.693S - Poisoning by other fibrinolysis-affecting drugs, assault, sequela Billable

  • T45.694A - Poisoning by other fibrinolysis-affecting drugs, undetermined, initial encounter Billable

  • T45.694D - Poisoning by other fibrinolysis-affecting drugs, undetermined, subsequent encounter Billable

  • T45.694S - Poisoning by other fibrinolysis-affecting drugs, undetermined, sequela Billable

  • T45.695A - Adverse effect of other fibrinolysis-affecting drugs, initial encounter Billable

  • T45.695D - Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter Billable

  • T45.695S - Adverse effect of other fibrinolysis-affecting drugs, sequela Billable

  • T45.696A - Underdosing of other fibrinolysis-affecting drugs, initial encounter Billable

  • T45.696D - Underdosing of other fibrinolysis-affecting drugs, subsequent encounter Billable

  • T45.696S - Underdosing of other fibrinolysis-affecting drugs, sequela Billable

  • T45.7X1A - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), initial encounter Billable

  • T45.7X1D - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), subsequent encounter Billable

  • T45.7X1S - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), sequela Billable

  • T45.7X2A - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, initial encounter Billable

  • T45.7X2D - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, subsequent encounter Billable

  • T45.7X2S - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, sequela Billable

  • T45.7X3A - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, initial encounter Billable

  • T45.7X3D - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, subsequent encounter Billable

  • T45.7X3S - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, sequela Billable

  • T45.7X4A - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, initial encounter Billable

  • T45.7X4D - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, subsequent encounter Billable

  • T45.7X4S - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, sequela Billable

  • T45.7X5A - Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter Billable

  • T45.7X5D - Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter Billable

  • T45.7X5S - Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela Billable

  • T45.7X6A - Underdosing of anticoagulant antagonist, vitamin K and other coagulants, initial encounter Billable

  • T45.7X6D - Underdosing of anticoagulant antagonist, vitamin K and other coagulants, subsequent encounter Billable

  • T45.7X6S - Underdosing of anticoagulant antagonist, vitamin K and other coagulants, sequela Billable

  • T45.8X1A - Poisoning by other primarily systemic and hematological agents, accidental (unintentional), initial encounter Billable

  • T45.8X1D - Poisoning by other primarily systemic and hematological agents, accidental (unintentional), subsequent encounter Billable

  • T45.8X1S - Poisoning by other primarily systemic and hematological agents, accidental (unintentional), sequela Billable

  • T45.8X2A - Poisoning by other primarily systemic and hematological agents, intentional self-harm, initial encounter Billable

  • T45.8X2D - Poisoning by other primarily systemic and hematological agents, intentional self-harm, subsequent encounter Billable

  • T45.8X2S - Poisoning by other primarily systemic and hematological agents, intentional self-harm, sequela Billable

  • T45.8X3A - Poisoning by other primarily systemic and hematological agents, assault, initial encounter Billable

  • T45.8X3D - Poisoning by other primarily systemic and hematological agents, assault, subsequent encounter Billable

  • T45.8X3S - Poisoning by other primarily systemic and hematological agents, assault, sequela Billable

  • T45.8X4A - Poisoning by other primarily systemic and hematological agents, undetermined, initial encounter Billable

  • T45.8X4D - Poisoning by other primarily systemic and hematological agents, undetermined, subsequent encounter Billable

  • T45.8X4S - Poisoning by other primarily systemic and hematological agents, undetermined, sequela Billable

  • T45.8X5A - Adverse effect of other primarily systemic and hematological agents, initial encounter Billable

  • T45.8X5D - Adverse effect of other primarily systemic and hematological agents, subsequent encounter Billable

  • T45.8X5S - Adverse effect of other primarily systemic and hematological agents, sequela Billable

  • T45.8X6A - Underdosing of other primarily systemic and hematological agents, initial encounter Billable

  • T45.8X6D - Underdosing of other primarily systemic and hematological agents, subsequent encounter Billable

  • T45.8X6S - Underdosing of other primarily systemic and hematological agents, sequela Billable

  • T45.91XA - Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), initial encounter Billable

  • T45.91XD - Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), subsequent encounter Billable

  • T45.91XS - Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), sequela Billable

  • T45.92XA - Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, initial encounter Billable

  • T45.92XD - Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, subsequent encounter Billable

  • T45.92XS - Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, sequela Billable

  • T45.93XA - Poisoning by unspecified primarily systemic and hematological agent, assault, initial encounter Billable

  • T45.93XD - Poisoning by unspecified primarily systemic and hematological agent, assault, subsequent encounter Billable

  • T45.93XS - Poisoning by unspecified primarily systemic and hematological agent, assault, sequela Billable

  • T45.94XA - Poisoning by unspecified primarily systemic and hematological agent, undetermined, initial encounter Billable

  • T45.94XD - Poisoning by unspecified primarily systemic and hematological agent, undetermined, subsequent encounter Billable

  • T45.94XS - Poisoning by unspecified primarily systemic and hematological agent, undetermined, sequela Billable

  • T45.95XA - Adverse effect of unspecified primarily systemic and hematological agent, initial encounter Billable

  • T45.95XD - Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter Billable

  • T45.95XS - Adverse effect of unspecified primarily systemic and hematological agent, sequela Billable

  • T45.96XA - Underdosing of unspecified primarily systemic and hematological agent, initial encounter Billable

  • T45.96XD - Underdosing of unspecified primarily systemic and hematological agent, subsequent encounter Billable

  • T45.96XS - Underdosing of unspecified primarily systemic and hematological agent, sequela Billable

  • T45.AX1A - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), initial encounter Billable

  • T45.AX1D - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), subsequent encounter Billable

  • T45.AX1S - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), sequela Billable

  • T45.AX2A - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, initial encounter Billable

  • T45.AX2D - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, subsequent encounter Billable

  • T45.AX2S - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, sequela Billable

  • T45.AX3A - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, initial encounter Billable

  • T45.AX3D - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, subsequent encounter Billable

  • T45.AX3S - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, sequela Billable

  • T45.AX4A - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, initial encounter Billable

  • T45.AX4D - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, subsequent encounter Billable

  • T45.AX4S - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, sequela Billable

  • T45.AX5A - Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, initial encounter Billable

  • T45.AX5D - Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter Billable

  • T45.AX5S - Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, sequela Billable

  • T45.AX6A - Underdosing of immune checkpoint inhibitors and immunostimulant drugs, initial encounter Billable

  • T45.AX6D - Underdosing of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter Billable

  • T45.AX6S - Underdosing of immune checkpoint inhibitors and immunostimulant drugs, sequela Billable